Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Cadrenal Therapeutics, Inc. from 31 Dec 2022 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Cadrenal Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Dec 2022 to 30 Jun 2024.
Cadrenal Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Jun 2024 was $132, a 95% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Cadrenal Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$132	-$2,395	-95%	30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q1 2024	$456	-$3,101	-87%	31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$969	-$3,780	-80%	31 Dec 2023	10-K	11 Mar 2024	2023	FY
Q3 2023	$1,662			30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$2,527			30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$3,557			31 Mar 2023	10-Q	10 May 2023	2023	Q1
Q4 2022	$4,749			31 Dec 2022	10-K	30 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.